(NewsNation) — Millions of Americans fighting obesity faced a setback last month when the Trump administration declined to allow Medicare and Medicaid to cover popular weight loss drugs like Wegovy and Zepbound.
The Centers for Medicare & Medicaid Services last month rejected a Biden proposal that would have required Medicare and Medicaid to cover the drugs. According to The New York Times, the most popular of the drugs are Wegovy, made by Novo Nordisk, and Zepbound, made by Eli Lilly.
The drugs for diabetes are manufactured under the names Ozempic and Mounjaro. Medicare covers the medications for diabetic patients, as well as a small subset who are obese and have a heart condition or sleep apnea.
State
Read More
Knowing how Medicare is evolving and which benefits you can rely on will help you focus on whether Original Medicare or a particular Medicare Advantage plan will serve you best. Medical costs are going up every year and there are a number of factors at work; inflation and medical advancements, such as biosimilars, are helping to drive costs up.
According to Fidelity, a 65-year-old retiring in 2024 can expect to spend an average of $165,000 in health care and medical expenses throughout retirement. One way to manage your costs is by selecting the best Medicare policy for you.
While we are about five months away from Medicare open enrollment, the state of Medicare has been
Read More
Ensuring that Medicare works for seniors and people with disabilities, and that people with Medicare have access to robust, stable, high-quality, and affordable options for the coverage they need, are top priorities for the Centers for Medicare & Medicaid Services (CMS). As part of this, CMS is focused on continuing to improve the quality of the MA and Part D programs. As the results for the 2025 Star Ratings demonstrate, CMS continues to implement enhancements to the MA and Part D Star Ratings program to promote continual quality improvement to help ensure that Medicare enrollees receive high quality care and to incentivize plans to continue to strive for higher quality.
CMS publishes the Medicare Advantage (Medicare Part C) and Medicare Part
Read More